当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析 - 资产负债表

恩华药业

(002262)

  

流通市值:191.51亿  总市值:219.51亿
流通股本:8.84亿   总股本:10.13亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金1,257,078,649.381,221,996,648.721,424,269,934.081,449,605,634.51
  交易性金融资产2,912,000,0002,522,000,0002,706,000,0002,569,000,000
  应收票据及应收账款1,577,795,178.081,756,584,017.941,759,471,783.31,471,866,541.37
        应收账款1,577,795,178.081,756,584,017.941,759,471,783.31,471,866,541.37
  应收款项融资76,669,266.4278,856,922.2470,830,187.5995,367,480.99
  预付款项138,428,281.86167,989,357.76116,131,433.449,408,564.16
  其他应收款合计109,673,799.284,239,580.7176,319,179.8421,987,590.49
  存货921,153,189.57858,199,023.8695,228,046.98756,783,513.22
  其他流动资产39,245,734.1446,336,070.2326,367,124.648,933,107.86
  流动资产合计7,032,044,098.656,736,201,621.46,874,617,689.796,462,952,432.6
非流动资产:
  长期股权投资154,384,767.88149,338,965.8146,322,299.11143,911,402.44
  其他权益工具投资51,162,880.5551,162,880.5551,162,880.5551,162,880.55
  其他非流动金融资产8,000,000---
  投资性房地产48,130,461.0948,688,343.2249,246,225.3549,804,107.48
  固定资产1,253,717,541.431,225,080,773.931,232,754,863.171,222,358,056.9
  在建工程320,379,030.36335,924,397.75321,073,178.77365,937,574.8
  使用权资产34,267,49938,045,863.4540,494,075.2645,920,686.5
  无形资产301,201,826.53308,889,172.63285,185,138.31249,078,026.8
  开发支出359,487,994.54303,518,151.48291,298,502.01308,766,710.25
  长期待摊费用175,593,952.63190,857,040.38205,828,376.86220,263,027.14
  递延所得税资产71,818,849.676,296,243.3275,776,840.373,903,677.15
  其他非流动资产96,169,845.6971,042,635.9568,878,318.3429,173,337.55
  非流动资产合计2,874,314,649.32,798,844,468.462,768,020,698.032,760,279,487.56
  资产总计9,906,358,747.959,535,046,089.869,642,638,387.829,223,231,920.16
流动负债:
  短期借款-40,000,00061,000,00030,000,000
  应付票据及应付账款666,428,698.69560,463,025.68622,339,871.09556,948,702.08
  其中:应付票据364,532,552.63274,780,519.7309,787,375.97311,845,853.58
        应付账款301,896,146.06285,682,505.98312,552,495.12245,102,848.5
  合同负债67,911,903.4537,384,369.0970,114,770.0830,013,269.51
  应付职工薪酬50,400.01172,000172,0004,979,542.8
  应交税费157,662,100.98202,574,492.7151,682,401.48154,795,451.32
  其他应付款合计135,464,226.4222,330,852.87276,024,864.44295,302,487.37
  一年内到期的非流动负债14,266,636.4816,762,451.1318,147,548.717,794,114.83
  其他流动负债7,555,708.23,598,481.377,854,030.832,405,967.28
  流动负债合计1,049,339,674.211,083,285,672.841,207,335,486.621,092,239,535.19
非流动负债:
  长期借款230,000230,000230,000230,000
  租赁负债12,951,625.4415,052,240.7915,573,434.6319,694,594.05
  预计负债24,373,279.4724,373,279.4724,373,279.4733,543,279.47
  递延收益49,628,478.6649,628,478.6649,628,478.6649,628,478.66
  递延所得税负债316,762.85---
  非流动负债合计87,500,146.4289,283,998.9289,805,192.76103,096,352.18
  负债合计1,136,839,820.631,172,569,671.761,297,140,679.381,195,335,887.37
所有者权益(或股东权益):
  实收资本(或股本)1,012,971,4231,015,786,5831,015,786,5831,015,786,583
  资本公积253,854,454.12281,302,264.12281,302,264.12281,302,264.12
  减:库存股35,898,308.868,300,800.468,300,800.468,300,800.4
  其他综合收益-1,113,608.34-1,113,608.34-1,113,608.34-1,113,608.34
  盈余公积508,088,396508,088,396508,088,396508,088,396
  未分配利润7,061,236,807.26,655,740,080.416,638,785,694.046,321,371,740.37
  归属于母公司股东权益合计8,799,139,163.188,391,502,914.798,374,548,528.428,057,134,574.75
  少数股东权益-29,620,235.86-29,026,496.69-29,050,819.98-29,238,541.96
  股东权益合计8,769,518,927.328,362,476,418.18,345,497,708.448,027,896,032.79
  负债和股东权益合计9,906,358,747.959,535,046,089.869,642,638,387.829,223,231,920.16
公告日期2026-10-242026-08-182026-04-182026-04-18
审计意见(境内)标准无保留意见
TOP↑